Literature DB >> 33825493

Differential responses to e-cig generated aerosols from humectants and different forms of nicotine in epithelial cells from nonsmokers and smokers.

Yael-Natalie H Escobar1, Cameron B Morrison2, Yuzhi Chen3, Elise Hickman1, Charlotte A Love1, Meghan E Rebuli1,4, Jason D Surratt3,5, Camille Ehre2,4, Ilona Jaspers1,4.   

Abstract

In the United States, millions of adults use electronic cigarettes (e-cigs), and a majority of these users are former or current cigarette smokers. It is unclear, whether prior smoking status affects biological responses induced by e-cigs. In this study, differentiated human nasal epithelial cells (hNECs) from nonsmokers and smokers at air-liquid interface were acutely exposed to the e-cig generated aerosols of humectants, propylene glycol (PG), and glycerol (GLY). Mucin levels were examined in the apical washes, and cytokine levels were assessed in the basolateral supernatants 24 h postexposure. The aerosol from the GLY exposure increased mucin 5, subtype AC (MUC5AC) levels in the apical wash of hNECs from nonsmokers, but not smokers. However, the aerosol from GLY induced pro-inflammatory responses in hNECs from smokers. We also exposed hNECs from nonsmokers and smokers to e-cig generated aerosol from PG:GLY with freebase nicotine or nicotine salt. The PG:GLY with freebase nicotine exposure increased MUC5AC and mucin 5, subtype B (MUC5B) levels in hNECs from nonsmokers, but the nicotine salt exposure did not. The PG:GLY with nicotine salt exposure increased pro-inflammatory cytokines in hNECs from smokers, which was not seen with the freebase nicotine exposure. Taken together, these data indicate that the e-cig generated aerosols from the humectants, mostly GLY, and the type of nicotine used cause differential effects in airway epithelial cells from nonsmokers and smokers. As e-cig use is increasing, it is important to understand that the biological effects of e-cig use are likely dependent on prior cigarette smoke exposure.

Entities:  

Keywords:  GLY; PG; e-cigs; nicotine; smokers

Mesh:

Substances:

Year:  2021        PMID: 33825493      PMCID: PMC8285624          DOI: 10.1152/ajplung.00525.2020

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   6.011


  64 in total

1.  The prevalence, correlates and reasons for using electronic cigarettes among New Zealand adults.

Authors:  Judy Li; Rhiannon Newcombe; Darren Walton
Journal:  Addict Behav       Date:  2015-02-20       Impact factor: 3.913

2.  Reduced expression of IRF7 in nasal epithelial cells from smokers after infection with influenza.

Authors:  Ilona Jaspers; Katherine M Horvath; Wenli Zhang; Luisa E Brighton; Johnny L Carson; Terry L Noah
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-30       Impact factor: 6.914

3.  Acrolein-induced MUC5ac expression in rat airways.

Authors:  M T Borchers; S E Wert; G D Leikauf
Journal:  Am J Physiol       Date:  1998-04

Review 4.  Epidemiology of chronic mucus hypersecretion and obstructive airways disease.

Authors:  F E Speizer; I B Tager
Journal:  Epidemiol Rev       Date:  1979       Impact factor: 6.222

5.  Electronic Cigarette Use Among Young, Middle-aged, and Older Adults in the United States in 2017 and 2018.

Authors:  Wei Bao; Buyun Liu; Yang Du; Linda G Snetselaar; Robert B Wallace
Journal:  JAMA Intern Med       Date:  2020-02-01       Impact factor: 21.873

6.  Cinnamaldehyde in flavored e-cigarette liquids temporarily suppresses bronchial epithelial cell ciliary motility by dysregulation of mitochondrial function.

Authors:  Phillip W Clapp; Katelyn S Lavrich; Catharina A van Heusden; Eduardo R Lazarowski; Johnny L Carson; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-03       Impact factor: 5.464

7.  Application of a multi-layer systems toxicology framework for in vitro assessment of the biological effects of Classic Tobacco e-liquid and its corresponding aerosol using an e-cigarette device with MESH™ technology.

Authors:  Anita R Iskandar; Filippo Zanetti; Diego Marescotti; Bjorn Titz; Alain Sewer; Athanasios Kondylis; Patrice Leroy; Vincenzo Belcastro; Laura Ortega Torres; Stefano Acali; Shoaib Majeed; Sandro Steiner; Keyur Trivedi; Emmanuel Guedj; Celine Merg; Thomas Schneider; Stefan Frentzel; Florian Martin; Nikolai V Ivanov; Manuel C Peitsch; Julia Hoeng
Journal:  Arch Toxicol       Date:  2019-09-07       Impact factor: 5.153

Review 8.  Airway Mucus and Asthma: The Role of MUC5AC and MUC5B.

Authors:  Luke R Bonser; David J Erle
Journal:  J Clin Med       Date:  2017-11-29       Impact factor: 4.241

9.  E-cigarette Use Among Middle and High School Students - United States, 2020.

Authors:  Teresa W Wang; Linda J Neff; Eunice Park-Lee; Chunfeng Ren; Karen A Cullen; Brian A King
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-09-18       Impact factor: 17.586

Review 10.  Electronic cigarettes: product characterisation and design considerations.

Authors:  Christopher J Brown; James M Cheng
Journal:  Tob Control       Date:  2014-05       Impact factor: 7.552

View more
  3 in total

1.  Transcriptomic Evidence That Switching from Tobacco to Electronic Cigarettes Does Not Reverse Damage to the Respiratory Epithelium.

Authors:  Giovanna L Pozuelos; Meenakshi Kagda; Matine A Rubin; Maciej L Goniewicz; Thomas Girke; Prue Talbot
Journal:  Toxics       Date:  2022-07-04

2.  Vegetable glycerin e-cigarette aerosols cause airway inflammation and ion channel dysfunction.

Authors:  Michael D Kim; Samuel Chung; John S Dennis; Makoto Yoshida; Carolina Aguiar; Sheyla P Aller; Eliana S Mendes; Andreas Schmid; Juan Sabater; Nathalie Baumlin; Matthias Salathe
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

3.  Woodsmoke particle exposure prior to SARS-CoV-2 infection alters antiviral response gene expression in human nasal epithelial cells in a sex-dependent manner.

Authors:  Stephanie A Brocke; Grant T Billings; Sharon Taft-Benz; Neil E Alexis; Mark T Heise; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-02-02       Impact factor: 6.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.